Longevi­ty in­vestors look to add $200M to the ta­ble with new growth fund

Bold Cap­i­tal Part­ners, a life sci­ences and deep tech in­vestor, is rais­ing a new fund to sup­port biotechs and di­ag­nos­tics mak­ers fo­cused on “healthy hu­man …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.